Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Real-World Data
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network
Curr Oncol 2022 Feb 12;29(2)1047-1061, JW Law, D Mitra, HG Kaplan, T Alfred, AM Brufsky, B Emir, H McCracken, X Liu, RG Broome, C Zhang, C DiCristo, C ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.